Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock
RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Reviva Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Reviva Pharmaceuticals's enterprise value was -$13.85M on Oct 19, 2026, against $31.58M a year earlier. Over the last 5 years it ranged from -$16.72M to $125.14M, with a median of $28.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | -$13.85M | -196.3% |
| 2025 | Dec 31, 2025 | $14.38M | -74.6% |
| 2024 | Dec 31, 2024 | $56.60M | -45.7% |
| 2023 | Dec 29, 2023 | $104.33M | +58.3% |
| 2022 | Dec 30, 2022 | $65.92M | +964.1% |
| 2021 | Dec 31, 2021 | $6.19M | -75.4% |
| 2020 | Dec 31, 2020 | $25.15M | – |
See a number that looks wrong?